Skip to main content
    S

    Shuttle Pharmaceuticals Inc (SHPH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $4.30
    +0.06 (+1.42%)

    Market Cap: $21.58M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Shuttle Pharmaceuticals Inc (SHPH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Shuttle Pharmaceuticals (SHPH) has a market cap of $21.58M and an enterprise value of $21.74M. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 0.74% above the market cap, as debt exceeds cash.

    Market Cap$21.58M
    Enterprise Value$21.74M
    Latest price (Nov 17, 2026)$4.30

    Key Dates

    Last Earnings DateSep 24, 2026
    Fiscal Year EndDecember

    Valuation Ratios

    P/B Ratio0.2x
    P/TBV Ratio0.4x

    Price Statistics

    The stock is down 81.47% over 52 weeks and trades 4.87% below its 50-day average.

    Beta (1Y)0.46
    52-Week Change-81.47%
    1-Month Change-8.90%
    3-Month Change+14.36%
    6-Month Change-29.39%
    Total Return (1Y)-81.47%
    Total Return (3Y CAGR)-83.57%
    Return vs SPY (1Y)-91.18%
    Max Drawdown (1Y)-88.88%
    Max Drawdown (3Y)-99.76%
    Sharpe Ratio (1Y)-1.14
    Correlation with SPY (1Y)0.05
    50-Day Average$4.52
    200-Day Average$6.12
    52-Week Range$2.58 to $27.30
    RSI (14 Days)40.8
    Average Volume (20 Days)32.18K

    Price chart

    Financial Position

    Current assets cover 0.11x current liabilities, and total debt is 0.01x shareholder equity.

    Current Ratio0.11x
    Quick Ratio0.11x
    Debt / Equity0.01x
    Interest Coverage10.78x

    Returns and Efficiency

    Return on invested capital is -45.97% and return on equity is -53.49% over the last 12 months.

    Return on Equity (ROE)-53.49%
    Return on Assets (ROA)-44.98%
    Return on Invested Capital (ROIC)-45.97%

    Scores

    SHPH has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$289.07K
    Operating Income-$11.22M
    Pretax Income-$10.26M
    Net Income-$10.26M
    EBITDA-$9.71M
    Reported EPS (TTM)-$22.09

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 84.09% of the $22.81M in total assets.

    Cash and Equivalents$90.24K
    Total Debt$250.00K
    Net Debt$159.76K
    Net Debt Per Share$0.16
    Working Capital-$3.08M
    Shareholder Equity$19.18M
    Book Value Per Share$18.90
    Tangible Book Value$10.53M
    Tangible Book Per Share$10.38
    Total Assets$22.81M
    Total Liabilities$3.63M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$6.58M
    FCF Per Share-$1.39
    Depreciation and Amortization$1.60M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Dividends and Yields

    SHPH does not pay a dividend.

    Buyback Yield-124.69%
    Shareholder Yield-124.69%

    Stock Splits

    The last split was a 1-for-10 reverse split on Jun 11, 2026.

    Last Split DateJun 11, 2026
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 6 similar companies, SHPH has the 5th highest ROIC.

    ROIC-45.97% vs -17.27% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs +3.38% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SHPH

    What is SHPH's market cap?

    Shuttle Pharmaceuticals has a market cap of $21.58M. Its enterprise value, which adds debt and subtracts cash, is $21.74M.

    How many shares of SHPH are outstanding?

    Shuttle Pharmaceuticals has 1.02M shares outstanding.

    Does SHPH pay a dividend?

    No. Shuttle Pharmaceuticals does not pay a dividend.

    How much debt does SHPH have?

    Shuttle Pharmaceuticals has $250.00K of total debt and $90.24K of cash and equivalents, a net debt position of $159.76K.